Cancer Bytes: Targeting the EGFR oncogene, breakthroughs in breast cancer research
Oct. 17, 2025
Image
Joyce A. Schroeder, PhD, cancer center member, professor, and department head of the University of Arizona Department of Molecular and Cellular Biology, discusses the science behind novel cancer treatments, the challenges of drug development, and the hope for more effective, less toxic therapies.
In this feature, Schroeder shares the latest breakthroughs in breast cancer research, focusing on how new drugs are targeting the EGFR oncogene—a key driver in cancer development and resistance. Discover how her lab is unraveling the complex interactions between cancer cells and the immune system, and learn about the journey from lab discoveries to real-world therapies.